These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23315240)
1. Novel fusion protein derived from vasostatin 30 and vasoinhibin II-14.1 potently inhibits coronary endothelial cell proliferation. Vazquez Rodriguez G; Gonzalez C; De Leon Rodriguez A Mol Biotechnol; 2013 Jul; 54(3):920-9. PubMed ID: 23315240 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin. Gu Q; Sun C; Luo J; Zhang T; Wang L Anticancer Drugs; 2014 Oct; 25(9):1044-51. PubMed ID: 24942148 [TBL] [Abstract][Full Text] [Related]
3. Expression and purification of soluble non-fusion vasostatin in Escherichia coli. Wu X; Li X; Su Z; Zheng Q; Xu H; Wu S; Feng Y; Zhao W Protein Pept Lett; 2005 Oct; 12(7):659-61. PubMed ID: 16522180 [TBL] [Abstract][Full Text] [Related]
4. An improved strategy for high-level production of human vasostatin120-180. Sun QM; Chen LL; Cao L; Fang L; Chen C; Hua ZC Biotechnol Prog; 2005; 21(4):1048-52. PubMed ID: 16080682 [TBL] [Abstract][Full Text] [Related]
5. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy. Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863 [TBL] [Abstract][Full Text] [Related]
6. Expression, purification and biological characterization of human vasostatin120-180 in Pichia pastoris. Lin Y; Yang X; Lu M; Zhuang H; Hua ZC Protein Expr Purif; 2013 Dec; 92(2):141-7. PubMed ID: 24096091 [TBL] [Abstract][Full Text] [Related]
7. Thrombin Cleaves Prolactin Into a Potent 5.6-kDa Vasoinhibin: Implication for Tissue Repair. Zamora M; Robles JP; Aguilar MB; Romero-Gómez SJ; Bertsch T; Martínez de la Escalera G; Triebel J; Clapp C Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34418052 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin. Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330 [TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of the active fragment of human vasostatin Vs30 in Pichia pastoris SMD1168H. Calderon-Salais S; Velazquez-Bernardino P; Balderas-Hernandez VE; Barba de la Rosa AP; De Leon-Rodriguez A Protein Expr Purif; 2018 Apr; 144():40-45. PubMed ID: 29221829 [TBL] [Abstract][Full Text] [Related]
10. Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells. Peng XC; Wang M; Chen XX; Liu J; Xiao GH; Liao HL Mol Cell Biochem; 2014 Oct; 395(1-2):265-72. PubMed ID: 24997628 [TBL] [Abstract][Full Text] [Related]
11. Expression of biologically active kringle 5 domain of human plasminogen in Escherichia coli. Zhang HX; Fang L; Cheng J; Wei Z; Hua ZC Prep Biochem Biotechnol; 2005; 35(1):17-27. PubMed ID: 15704494 [TBL] [Abstract][Full Text] [Related]
12. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Pike SE; Yao L; Setsuda J; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Atreya CD; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G Blood; 1999 Oct; 94(7):2461-8. PubMed ID: 10498619 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior. Liu M; Imam H; Oberg K; Zhou Y Neuroendocrinology; 2005; 82(1):1-10. PubMed ID: 16293970 [TBL] [Abstract][Full Text] [Related]
14. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity. Fan J; Huang L; Sun J; Qiu Y; Zhou J; Shen Y J Biotechnol; 2015 Sep; 209():16-22. PubMed ID: 26072465 [TBL] [Abstract][Full Text] [Related]
15. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli. You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278 [TBL] [Abstract][Full Text] [Related]
16. Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization. Sun QM; Cao L; Fang L; Chen C; Dai J; Chen LL; Hua ZC Protein Expr Purif; 2005 Feb; 39(2):288-95. PubMed ID: 15642481 [TBL] [Abstract][Full Text] [Related]
17. Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis. Nguyen NQ; Tabruyn SP; Lins L; Lion M; Cornet AM; Lair F; Rentier-Delrue F; Brasseur R; Martial JA; Struman I Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14319-24. PubMed ID: 16973751 [TBL] [Abstract][Full Text] [Related]
18. Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. Huegel R; Velasco P; De la Luz Sierra M; Christophers E; Schröder JM; Schwarz T; Tosato G; Lange-Asschenfeldt B J Invest Dermatol; 2007 Jan; 127(1):65-74. PubMed ID: 16888632 [TBL] [Abstract][Full Text] [Related]
19. Expression of human plasminogen kringle 5 as fusion protein with truncated hIFNgamma gene in Escherichia coli. Lu H; Yuan H; Li Y J Biotechnol; 2002 Apr; 94(3):277-85. PubMed ID: 11861086 [TBL] [Abstract][Full Text] [Related]
20. Efficient refolding of the bifunctional therapeutic fusion protein VAS-TRAIL by a triple agent solution. Fan J; Wang Z; Huang L; Shen Y Protein Expr Purif; 2016 Sep; 125():68-73. PubMed ID: 26358405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]